CONTOUR® NEXT GEN 血糖監測系統
K 號:K223293 · 2022-11-18
廣告
器材摘要
常見問題
What is the CONTOUR® NEXT GEN Blood Glucose Monitoring System?
CONTOUR® NEXT GEN Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-11-18. The listed applicant is Ascensia Diabetes Care U.S., Inc.. The 510(k) number is K223293.
When did CONTOUR® NEXT GEN Blood Glucose Monitoring System receive FDA 510(k) clearance?
CONTOUR® NEXT GEN Blood Glucose Monitoring System received FDA 510(k) clearance on 2022-11-18, under 510(k) number K223293.
Who is the listed applicant for CONTOUR® NEXT GEN Blood Glucose Monitoring System?
The FDA 510(k) record lists Ascensia Diabetes Care U.S., Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CONTOUR® NEXT GEN Blood Glucose Monitoring System?
The FDA product code for CONTOUR® NEXT GEN Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。
其他以 Ascensia Diabetes Care U.S., Inc. 為申請人之記錄
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。
相關器械(代碼:NBW)
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。
廣告